Each day, more than 30 people in the U.S. sustain a spinal cord injury (SCI) that results in paralysis. More than half of these individuals lose the function of both their arms and legs. Health issues associated with inactivity are compounded for people with SCI. The risk of diabetes doubles. The risk of heart disease triples. The risk of stroke quadruples. Yet conventional responses to SCI fail to tackle the problem of inactivity.
Here at Spaulding, the approach is proactive rather than reactive. Spaulding’s research—based on the science of neuroplasticity—is already accelerating spinal cord injury recovery. An international trailblazer, Spaulding is the only clinical and research program in the world exploring new technologies that stimulate whole body exercise, bolstering physical resilience in SCI patients.
Spaulding is also the only hospital in the U.S. to be awarded the prestigious Model System designation in Traumatic Brain Injury and Burn Injury, all at the same time, by the National Institute on Disability, Independent Living and Rehabilitation Research.
J. Andrew Taylor, PhD, Principal Investigator
Cardiovascular Research Lab
Ted Teng, PhD, Principal Investigator
Laboratory of Spinal Cord Injury, Stem Cell and Neurofacilitation
Randy Trumbower, PhD, Principal Investigator
Ross Zafonte, DO, Principal Investigator
Paolo Bonato, PhD, Principal Investigator
Motion Analysis Lab
Clas Linnman, PhD, Principal Investigator
Leon Morales Quezada, MD, PhD, Principal Investigator
Spaulding Neuromodulation Center